The future of stem cell therapies for Parkinson disease

M Parmar, S Grealish, C Henchcliffe - Nature Reviews Neuroscience, 2020 - nature.com
Cell-replacement therapies have long been an attractive prospect for treating Parkinson
disease. However, the outcomes of fetal tissue-derived cell transplants in individuals with …

Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers

C Reitz, R Mayeux - Biochemical pharmacology, 2014 - Elsevier
The global prevalence of dementia is as high as 24 million, and has been predicted to
quadruple by the year 2050. In the US alone, Alzheimer disease (AD)–the most frequent …

Manganese-induced parkinsonism and Parkinson's disease: shared and distinguishable features

GF Kwakye, MMB Paoliello, S Mukhopadhyay… - International journal of …, 2015 - mdpi.com
Manganese (Mn) is an essential trace element necessary for physiological processes that
support development, growth and neuronal function. Secondary to elevated exposure or …

High-accuracy detection of early Parkinson's disease through multimodal features and machine learning

R Prashanth, SD Roy, PK Mandal, S Ghosh - International journal of …, 2016 - Elsevier
Early (or preclinical) diagnosis of Parkinson's disease (PD) is crucial for its early
management as by the time manifestation of clinical symptoms occur, more than 60% of the …

Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice

F Ba, WRW Martin - Parkinsonism & related disorders, 2015 - Elsevier
Abstract Background Accurate diagnosis of Parkinson disease (PD) and other degenerative
parkinsonian syndromes is important for management and prognostic purposes. Diagnosis …

[HTML][HTML] In vivo imaging of alpha-synuclein with antibody-based PET

S Roshanbin, M Xiong, G Hultqvist, L Söderberg… - …, 2022 - Elsevier
The protein alpha-synuclein (αSYN) plays a central role in synucleinopathies such as
Parkinsons's disease (PD) and multiple system atrophy (MSA). Presently, there are no …

[18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism

S Hellwig, F Amtage, A Kreft, R Buchert, OH Winz… - Neurology, 2012 - AAN Enterprises
Objective: Imaging of regional cerebral glucose metabolism with PET and striatal dopamine
D2/D3 receptors (D2R) with SPECT improves the differential diagnosis of parkinsonism. We …

Skin nerve misfolded α‐synuclein in pure autonomic failure and P arkinson disease

V Donadio, A Incensi, C Piccinini, P Cortelli… - Annals of …, 2016 - Wiley Online Library
Objective To characterize the expression in skin nerves of native (n‐syn) and misfolded
phosphorylated (p‐syn) α‐synucleins in pure autonomic failure (PAF) and idiopathic …

Association between early-onset Parkinson disease and 22q11. 2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical …

NJ Butcher, TR Kiehl, LN Hazrati, EWC Chow… - JAMA …, 2013 - jamanetwork.com
Importance Clinical case reports of parkinsonism co-occurring with hemizygous 22q11. 2
deletions and the associated multisystem syndrome, 22q11. 2 deletion syndrome (22q11 …

Automatic classification and prediction models for early Parkinson's disease diagnosis from SPECT imaging

R Prashanth, SD Roy, PK Mandal, S Ghosh - Expert Systems with …, 2014 - Elsevier
Early and accurate diagnosis of Parkinson's disease (PD) is important for early
management, proper prognostication and for initiating neuroprotective therapies once they …